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UCEmethylationThe nucleolus is a subnuclear compartment within the cell nucleus that serves as the site for ribosomal RNA
(rRNA) transcription and the assembly of ribosome subunits. Apart from its classical role in ribosomal biogenesis,
a number of cellular regulatory roles have recently been assigned to the nucleolus, including governing the induc-
tion of apoptosis. “Nucleolar stress” is a term that is used to describe a signaling pathway throughwhich the nu-
cleolus communicates with other subcellular compartments, including the mitochondria, to induce apoptosis. It
is an effective mechanism for eliminating cells that are incapable of performing protein synthesis efﬁciently due
to ribosome biogenesis defects. The down-regulation of rRNA transcription is a common cause of nucleolar func-
tion disruption that subsequently triggers nucleolar stress, and has been associatedwith the pathogenesis of neu-
rological disorders such as spinocerebellar ataxias (SCAs) and Huntington's diseases (HD). This article discusses
recent advances inmechanistic studies of how expanded CAG trinucleotide repeat RNA transcripts trigger nucle-
olar stress in SCAs, HD and other trinucleotide repeat disorders. This article is part of a Special Issue entitled: Role
of the Nucleolus in Human Disease.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
The nucleolus is a dynamic non-membrane-boundnuclear substruc-
ture in which the synthesis of ribosomal RNA (rRNA) and ribosome bio-
genesis take place [1]. In mammalian cells, nucleoli disintegrate during
cell division and reform after cells divide near the nucleolar organizer
regions (NORs) which are sites at which the tandemly-repeated rDNA
loci are located in chromosomes [2]. To perform its function, the nucle-
olus concentrates various cellular factors that are essential for rRNA
transcription/modiﬁcations and ribosome subunit assembly in three
morphologically distinct subnucleolar compartments: the ﬁbrillar center
(FC), the dense ﬁbrillar component (DFC) and the granular component
(GC). The FC is mainly responsible for the transcription of rRNA genes.
The DFC and GC are responsible for the processing of rRNA precursor
transcripts (pre-45S rRNA) and the assembly of ribosome subunits re-
spectively [2]. The protein content of each subnucleolar compartment
also reﬂects its cellular function. For example, FC is enriched with the
RNA polymerase I transcription machinery, such as Upstream Binding
Factor (UBF) [3] and Transcription Initiation Factor-IA (TIF-IA) [4].
This facilitates the efﬁcient transcription of rRNA genes and the ﬁnee Nucleolus in Human Disease.
esearch, School of Life Sciences,
Shatin, N.T., Hong Kong, China.
ights reserved.control of rRNA gene expression. The transcription of the rRNA genes
produces pre-45S rRNA precursors. Through a series of extensive pro-
cessing steps, the pre-45S rRNAs are converted into mature 28S, 18S
and 5.8S rRNAs, which are then ready to be complexed with individual
ribosomal proteins to form ribosome subunits [5]. Perturbation of any
step in ribosome biogenesis will slow down the cellular protein synthe-
sis rate and subsequently affect the normal functioning of a cell.
2. Initiation of rRNA gene transcription and its regulation
The human rRNA transcription unit is approximately 43 kb in size,
including 13 kb of pre-rRNA sequences and 30 kb of intergenic spacers
where most of the rRNA transcription regulatory elements are located,
including the core promoter and the upstream control element (UCE)
which are essential cis-acting components that govern rRNA transcrip-
tion initiation [6]. There are several hundred copies of rRNA genes in
the human genome. Transcription of rRNA genes is a highly regulated
process controlled at multiple levels including initiation, elongation
and termination (see [7] for review). Such tight control is to ensure an
adequate level of ribosome biogenesis to support cell survival and pre-
pare a cell to respond to external stimuli. Only rRNA transcription initi-
ation is discussed in this review. Both the UCE and the core promoter are
essential for efﬁcient rRNA transcription initiation. The UCE is located
approximately 150–200 bp upstream of the rRNA transcription start
site and serves as the binding target for the cellular trans-activating
proteins involved in RNA polymerase I-mediated transcription [8,9].
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step during the initiation phase of rRNA gene expression. It has
been shown that the nucleolar-speciﬁc HMG-box-containing protein
UBF ﬁrst binds to both the UCE and to the core promoter of the rRNA
loci to bring these two DNA elements into close proximity [10,11],
facilitating the association of a hetero-multimeric selectivity factor,
TIF-IB, onto the rRNA promoter. The UBF/TIF-IB complex subsequent-
ly recruits TIF-IA, which serves as a bridging molecule to recruit RNA
polymerase I to the rRNA promoter to build a functional PIC for tran-
scription initiation.
The transcription of rRNA genes can be regulated at multiple levels,
including post-translational and epigenetic. Protein phosphorylation
of TIF-IA and DNA methylation of the rRNA promoter are discussed
below. Protein phosphorylation of PIC components has proven a major
regulatorymechanism in controlling rRNA transcription [12]. Transcrip-
tional initiation factor-IA is an evolutionarily conserved transcription
factor involved in rRNA transcription [4] and is a critical component of
PIC. It is responsible for bridging RNA polymerase I and the rRNA pro-
moter to initiate rRNA transcription. In line with the essential role it
plays in ribosome biogenesis, knockout of TIF-IA gene function in mice
results in nucleolar disruption and apoptosis [13]. The activity of TIF-IA
is tightly regulated by protein phosphorylation. In response to the alter-
ations in both intra- and extra-cellular environments such as growth
conditions and cellular energy levels, TIF-IA undergoes hypo- and/or
hyper-phosphorylation [14–17]. An alteration in the phosphorylation
status of TIF-IA results in either potentiation or inhibition of rRNA tran-
scription initiation. Cavanaugh et al. (2002) showed that the unpho-
sphorylated form of TIF-IA was incapable of associating with RNA
polymerase I and activating rRNA transcription in mammalian cells
[17]. Oxidative stress is a well-known cellular stress, and Mayer et al.
(2005) identiﬁed TIF-IA as a substrate of c-Jun N-terminal kinase 2
(JNK2), further showing that upon stress JNK2 inactivates TIF-IA activity
by phosphorylating its Thr200 residue [18]. These ﬁndings reﬂect the
complex divergent effect of protein phosphorylation in the control of
TIF-IA activity. Szymanski et al. (2009) reported that the subcellular dis-
tribution of TIF-IA alters upon ribotoxic stress [19], indicating that rRNA
transcription initiation can be further regulated by protein nucleocyto-
plasmic shuttling. In the same year, DuRose et al. demonstrated that cel-
lular proteinmisfolding caused the inactivation of TIF-IA [20], this study
describes a role of unfolded protein response (UPR) in rRNA transcrip-
tion regulation (see the protein toxicity of polyQ disease and nucleolar
dysfunction section).
Although there are many hundreds of rRNA genes in the human ge-
nome [21–23], not all rRNA genes are simultaneously transcriptionally
active [24] and only up to 50% of all rRNA genes are transcribing at any
given time in a human cell [7,25]. This indicates the involvement of epi-
genetic control in rRNA transcription. Epigenetic changes refer to a com-
plex regulatory mechanism for controlling gene expression. The three
common epigenetic systems that govern rRNA transcription are CpG
DNA methylation, chromatin remodeling and histone post-translational
modiﬁcation. A number of modifying factors are involved in controlling
the epigenetic status of rRNA genes, including chromatin remodeling
factors, andDNA- andhistone-modifying enzymes (see [26] for review).
DNA methyltransferases are the enzymes responsible for covalently
attaching a methyl group to the 5′-position of cytosine in CpG dinucle-
otides. Clusters of CpG dinucleotides in the genome are called CpG
islands and they are themajor element that is subject to DNA hyperme-
thylation during gene silencing. In mice, DNA methylation of a single
CpGdinucleotide in the rRNA promoter is sufﬁcient to silence rRNA tran-
scription [27]. This highlights the crucial role of DNA methylation in
rRNA gene expression. There are 19 and 6 CpG dinucleotides in the
human UCE and core promoter respectively, and DNA methylation has
been reported in these regions [28,29]. Alterations in the methylation
status of rRNA genes have been observed in patients with various pa-
thologies [30–32], indicating the epigenetic dysregulation of rRNA ex-
pression in clinical conditions.Nucleolin (NCL), also known as C23, is a multi-functional protein
that is mainly localized in the nucleolus [33,34]. It is involved in various
steps of ribosome biogenesis, including rRNA transcription, rRNAmatu-
ration and ribosome assembly [35]. The four RNA-recognition motifs
(RRMs) in the central region of NCL enable it to associate with various
types of RNAmolecules. Nucleolin also binds to rRNA promoter DNA se-
quences [28,36,37]. Various groups have demonstrated the ability of
NCL to interact with UCE [28] of the rDNA promoter [36,37]. This indi-
cates that NCL is both a DNA- and RNA-binding protein. Cellular overex-
pression of NCL leads to the accumulation of pre-45S rRNAs [36]. In
contrast, knockdown of NCL expression reduces pre-45S rRNA levels
[28,36,37] and diminishes the binding of UBF on UCE [28,36]. As UBF is
involved in PIC formation [10,11], these observations suggest that NCL
plays a role in the regulation of rRNA transcription initiation. The role
that NCL plays in CpG methylation was deduced from cellular overex-
pression and knockdown studies of NCL. The overexpression of NCL
reduces UCE methylation, whereas UCE hypermethylation has been
observed in NCL-depleted cells [28]. Interestingly, this effect is UCE-
speciﬁc because no alteration of CpG dinucleotidesmethylationwas ob-
served in the core promoter [36] or non-rRNA genepromoters [28]. Taken
together, these observations suggest a new mechanism for regulating
rRNA transcription, in which NCL plays an essential role in regulating
themethylation status ofUCE [28], subsequently controlling the binding
of UBF to rRNA promoter [28,36]. Additional investigations are needed
to elucidate the details of how NCL modulates UCE CpG dinucleotide
methylation. Taken together, these ﬁndings indicate that rRNA tran-
scription initiation is one of the crucial cellular processes for cell surviv-
al, and is regulated at multiple levels.
3. Nucleolus function and neuronal cell death
Neurons are specialized cells responsible for transmitting chemical
and electrical signals in the nervous system. Neurons are generally con-
sidered as non-dividing cells, they grow in size and length after reaching
terminal differentiation. The alteration of nucleolar integrity is known
to be closely linked with neuronal growth and injury [38]. Extensive in-
vestigations have been conducted to elucidate the link between rRNA
transcription and neuronal activities (see [39] for review). For example,
the brain-derived neurotrophic factor is capable of promoting rRNA
transcription in developing neurons [40]. In contrast, the perturbation
of rRNA transcription leads to neuronal apoptosis [41] and neurodegen-
eration [42].
4. Nucleolar stress and neurodegeneration
“Nucleolar stress” is a term used to describe a signaling pathway
through which the nucleolus communicates with cytosolic compart-
ments to induce apoptosis [43]. Dysregulation of rRNA transcription is
the initial step in nucleolar stress induction [13], followed by cytosolic
accumulation of ribosomal proteins due to the reduced production of
rRNAs, stabilization of p53, and apoptosis. Under normal physiological
conditions, p53 is efﬁciently degraded via the ubiquitin proteasome sys-
tem (UPS). When cells undergo nucleolar stress, rRNA synthesis is af-
fected, which in turn compromises the rate of ribosome biogenesis. As
a result, unassembled free ribosomal proteins, the proteinaceous com-
ponent of ribosomes, accumulate in the cell. These free ribosomal pro-
teins associate with the E3 ubiquitin ligase and reduce the efﬁciency
of UPS-mediated p53 degradation [44]. The accumulation of p53 in the
cell then triggers downstream nucleolar stress responses, includingmi-
tochondrial cytochrome c release and caspase activation, which ulti-
mately lead to cell death. An increase in p53 protein level has been
observed in various neuronal cell death and neurodegenerative con-
ditions [41,42,45–47]. This is indicative of the involvement of nucleolar
stress in neuronal degeneration. Parlato et al. (2008) genetically ablated
the mouse TIF-IA gene in adult hippocampal neurons to investigate the
relationship between rRNA transcription and nucleolar stress in the
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levels in neurons of the TIF-IA conditional knockout animals [42]. A sim-
ilar observation was also made when TIF-IA function was perturbed in
dopaminergic neurons [48]. An increased level of p53 and activation
of caspase 3 were also reported in TIF-IA knockout mice [42], indicating
that perturbation of TIF-IA function causes nucleolar stress activation in
neurons. It is now known that several human neuropathological condi-
tions are associatedwith different aspects of nucleolar dysfunction [39],
and thus understanding themolecular events that trigger nucleolar dys-
function in individual disorders will allow us to better understand the
role of the nucleolus in neuronal functions and pathologies.
5. Polyglutamine diseases
Trinucleotide-repeat disorders (TRDs) are caused by a triplet nucle-
otide repeat expansion in the human genome [49]. These diseases range
from developmental disorders to late onset neurodegenerative dis-
eases [50]. A subgroup of TRDs is caused by the genomic expansion of
glutamine-encoding CAG triplet repeats in the coding region of disease
genes, and they are collectively termed polyglutamine (polyQ) diseases.
Polyglutamine disorders include HD, dentatorubral-pallidoluysian atro-
phy (DRPLA), spinal and bulbar muscular atrophy (SBMA), and SCA
types 1, 2, 3 (also known as Machado–Joseph disease), 6, 7 and 17 [51].
6. Protein toxicity of polyQ disease and nucleolar dysfunction
Expanded polyQ domain-containing proteins are misfolded, and
exist in diverse biophysical states and conformations. These different
forms of polyQ protein have been reported to contribute, to various ex-
tents, to polyQ toxicity [52]. In response to compromised cellular pro-
tein folding capability, a series of signaling cascades are up-regulated
to halt protein synthesis allowing cells to have the chance to refold/de-
grade the misfolded proteins. These pathways are collectively referred
to as the unfolded protein response (UPR). DuRose et al. (2009) showed
that protein kinaseR-like endoplasmic reticulumkinase (PERK) activity,
a sensor protein of UPR, is involved in the down-regulation of rRNA
transcription when cells are under UPR [20]. In an independent study,
Thomas et al. (2005) demonstrated that PERK activation enhanced
polyQ toxicity [53]. These observations suggest a potential link between
protein misfolding and nucleolar stress in polyQ toxicity.
With the use of a panel of antibodies against different epitopes of the
mutantHtt protein, the disease protein for HD, Trettel et al. (2000) iden-
tiﬁed a speciﬁc form of mutant Htt that localizes to the nucleolus [54].
Although further investigation is needed to unveil the effect of this par-
ticular form of Htt on nucleolar function, this study implies the involve-
ment of expanded polyQ disease protein in nucleolar dysfunction. Chan
et al. (2011) demonstrated that the expanded polyQ domain per se pos-
sesses nuclear export signal activity that is capable of mediating the di-
rectional nuclear-to-cytoplasmic transport of expanded polyQ domain-
containing proteins, and that such protein nuclear export events are
mediated by the exportin-1 (Xpo1) nuclear export receptor [55]. The
authors also showed that down-regulation of Xpo1 caused the mutant
protein to concentrate in the cell nucleus in animal polyQ disease
models [55]. The nuclear accumulation of expanded polyQ proteins
could potentially facilitate their nucleolar localization and thus triggers
nucleolar stress induction in polyQ disease.
7. RNA toxicity of polyQ disease and nucleolus dysfunction
It is now known that the expression of expanded CAG mutant tran-
scripts per se is cytotoxic [51,56–58]. Expanded polyQ disease proteins
and CAG transcripts are two distinct pathogenic species in polyQ degen-
eration. Although they do share some common pathogenic pathways
[59], expanded CAG transcript-speciﬁc pathogenic pathways also exist
and contribute signiﬁcantly to polyQ degeneration [60]. Transcripts car-
rying an expanded CAG repeats fold into stable RNA hairpin structuresand form RNA foci [51,57]. Interestingly, any internal interruption of
the continuity of the expanded CAG repeat transcripts interferes with
the stability of the hairpin structure [61] and/or reduces RNA-mediated
toxicity [51,56–58]. We discuss the pathogenic role of expanded CAG
transcripts in the nuclear compartment, particularly the nucleolus.
In their subcellular fractionation study, Tsoi et al. (2011) observed
that mutant transcripts carrying expanded CAG repeats predominantly
localize to the nuclear compartment in a time-dependent fashion in an-
imal polyQ disease models [62]. However, no such aberrant localization
was observed for the unexpanded control transcripts. This indicates a
CAG length-speciﬁc phenomenon. Under normal conditions, following
gene transcription mRNA transcripts are exported from the nucleus to
the cytosol for protein translation [63]. An accumulation of expanded
CAG transcripts in the nuclear compartment thus implies that mRNA
nuclear export is involved in such aberrant nucleocytoplasmic distribu-
tion of RNAs. Tsoi et al. (2011) performed a genetic modiﬁer screen in
Drosophila to gain insights into the molecular mechanism that governs
nuclear export of expandedCAG transcripts, and identiﬁed theDrosophila
ortholog of U2 small nucleoprotein auxiliary factor 65 (U2AF65),U2AF50,
as a genetic modiﬁer [62]. Knockdown ofU2AF50 expression intensiﬁed
the nuclear accumulation of expanded CAG transcripts and enhanced
RNA toxicity in vivo [62]. The U2AF50/65 protein has been shown to
mediate the nuclear export of cellular intronless mRNAs in both mam-
malian cells [64] and Drosophila [65]. Through a series of biochemical
analyses, the authors identiﬁed a trimeric RNA/protein complex that is
responsible for mediating nuclear export of expanded CAG transcripts.
This complex consists of the expanded CAG transcript, U2AF65 and
the nuclear RNA export factor 1 (NXF1, [63]). In this complex, U2AF65
functions as an adaptor protein to dock expanded CAG transcripts onto
the NXF1 receptor for nuclear export [62]. There are three RNA recogni-
tion motifs (RRMs) on U2AF65, and RRM3 is necessary and sufﬁcient to
mediate the interaction between U2AF65 and expanded CAG tran-
scripts. Based on this observation, we now understand that in addition
to the normal cellular poly(A) + mRNA exportmechanisms [63], amu-
tant transcript-speciﬁc export pathway also exists to facilitate the
nucleocytoplasmic translocation of pathogenic RNA molecules out of
the cell nucleus. Interestingly, the expression levels of U2AF65 declines
with age, and such reduction diminishes the U2AF65-mediated nuclear
export of expanded CAG transcripts [62]. Notably, knockdown of
U2AF65 expression in cells induces caspase 3 activation [62], suggesting
that nuclear retention of expanded CAG transcripts serves as a pro-
apoptotic signal and that the cell nucleus is a subcellular compartment
for expanded CAG transcripts to mediate toxicity.
As a follow-up study, Tsoi et al. (2012) demonstrated that transcripts
carrying expanded CAG repeats co-localize with the nucleolar marker,
ﬁbrillarin, within the nucleus [28]. As the nucleolus is a major site for
rRNA transcription, the authors determined pre-45S rRNA levels, and
found that rRNA transcription is to be reduced in both polyQ patient
cell lines and a transgenicmousediseasemodel. To study the toxic effect
of expanded CAG transcripts without any inﬂuence of polyQ protein
toxicity, an expanded 100 CAG repeats are inserted in the 3′ untranslated
region of a DsRed reporter construct (DsRedCAG100). When DsRedCAG100
transcripts were expressed in vivo in the Drosophila nervous system, a
compromised rRNA transcription was detected in the degenerating an-
imals [28]. It has been reported that DNAmethylation of rRNA promoter
causes down-regulation of rRNA transcription [27]. The authors also ob-
served UCE hypermethylation in cells that expressed an untranslated
expanded CAG construct [28]. This indicates an epigenetic dysregula-
tion of rRNA promoter in expanded CAG RNA toxicity. Tsoi et al. (2012)
next took a biochemical approach to unveiling the mechanism behind
expanded CAG transcript-induced UCE hypermethylation and found
that NCL interacts directly and speciﬁcally with expanded CAG tran-
scripts via its RRM domains [28]. Nucleolin function is essential for
rRNA transcription. It binds to UCE [28] of the rRNA promoter [36,37],
and protectsUCE fromCpGhypermethylation [28]. Upon the expression
of expanded CAG transcripts in cells, the mutant transcripts compete
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NCL and UCE, and is followed by CpG hypermethylation and a reduction
in UBF binding to the rRNA promoter. As a consequence, the transcrip-
tion of rRNA is down-regulated. Experimentally, the authors demonstrat-
ed amutually exclusive interaction between NCL/UCE andNCL/expanded
CAG transcripts in mammalian cells [28] that provides a faithful molec-
ular explanation of how the expandedmutant RNAs disrupt the cellular
function of NCL.Whether NCL is sequestered to RNA foci, which serve as
a physical barrier to stop NCL from binding to UCE, or it associates with
monomeric expanded CAG transcripts remains to be addressed. An an-
swer to this questionwill surely provide uswith additional insights into
whether any higher order inter-molecular organization of the mutant
transcripts (e.g. RNA foci) is involved in expanded CAG transcript-
mediated nucleolar stress induction in polyQ disease.
8. Interactions between RRM-containing proteins and expanded
CAG transcripts
Although RRMs deﬁne a protein domain family that mediates RNA-
protein interactions [66], theU2AF65RRM3domainwas initially report-
ed to be a protein–protein interaction domain responsible for interacting
with splicing factor 1 during early spliceosome assembly [67]. Because of
its ability to interact with protein instead of RNA, the U2AF65 RRM3 is
classiﬁed as a member of the noncanonical RRM subfamily [68]. Atypical
RRMs are characterized by the existence of acidic amino acid residues in
one of the helices, and are critically involved in protein–protein interac-
tion. In 2011, Tsoi et al. reported the interaction between U2AF65 RRM3
domain and expanded CAG transcripts [62], demonstrating the RNA-
binding property of this noncanonical RRM. Given the unusual structural
feature of U2AF65 RRM3 [67] and the signature hairpin stem loop struc-
ture of expanded CAG RNA transcripts [51,57], it is speculated that the
interaction mode(s) between U2AF65 and expanded CAG transcripts
would be distinct from any canonical RRM/RNA binding [66]. Despite
this, the speciﬁc interaction between expanded CAG transcripts and
U2AF65 leads to a functional consequence, that is RNA nuclear export
of the expanded transcripts [62]. Interestingly, in addition to the inter-
action with noncanonical RRM, expanded CAG transcripts also interact
with canonical RRMs in NCL [28]. Rather thanmediating any functional
consequence, the binding of NCL on expanded CAG transcripts prevents
it from associating with UCE and subsequently induces nucleolar stress
[28,69]. We now know that expanded CAG transcripts adopt different
stem loop conformations [51,57]. Possibly, certain conformations ofFig. 1. A schematic diagram describing the various players involved in CAG RNA-medexpanded CAG transcripts are capable of sequestering cellular factors
to RNA foci, such as the alternative splicing regulator muscleblind
[70–73], consequently leading to cellular dysfunctions [51,56–58].
When expanded CAG transcripts interact with [62] and/or recruit cellu-
lar factors to RNA foci [70–73], these binding events may induce a
change of conformation of the RNAs that enables them to further associ-
ate with additional cellular factors. It is thus speculated that any preced-
ing RNA/cellular protein interaction would generate new interaction
surface(s) on the expanded CAG transcripts. This may, in part, explain
how expanded CAG transcripts impair diverse cellular activities in
polyQ degeneration [51,56–58]. However, this induced RNA/protein in-
teraction surface hypothesis remains to be validated.
9. The role of NCL and nucleolar function in other
neurological diseases
Apart from polyQ degeneration, NCL has also been implicated in the
pathology of other neurological disorders. Ataxia with oculomotor
apraxia type 1 (AOA1) is an autosomal recessive early-onset cerebellar
ataxia caused by missense or truncation mutations in the aprataxin
gene [74,75]. Interestingly, a marked degradation of NCL has been re-
ported in AOA1 patient cells [76]. Because knockdown of NCL expres-
sion causes the down-regulation of rRNA transcription [28,36,37], the
degradation of NCL in patients implies the involvement of nucleolar
stress in the pathogenesis of AOA1. Parkinson's disease (PD) is classiﬁed
as a progressive neurodegenerative movement disorder. Both genetic
and environmental factors contribute to PD.Mann and Yates (1982) ob-
served a reduction of nucleolar volume in the substantia nigra of PD pa-
tients [77]. In an independent investigation, nucleolar integrity was also
reported to be disrupted in the dopaminergic neurons of PD patients
[48]. Alpha-synuclein and DJ-1 are two proteins that are associated
with idiopathic and/or inherited PD. A proteomic study reported that
both of these PD disease proteins are capable of interacting with NCL
[78]. At the biochemical level, NCL expression was found to be down-
regulated in PD patients [79]. These observations suggest that nucleolar
function perturbation in PD may occur through the down-regulation of
cellular NCL function. Whether the down-regulation of NCL reported in
AOA1 and PD is triggered by themutant RNA and/or protein awaits fur-
ther investigations. Similar to PD, a reduction in nucleolar volume was
observed in patients with Alzheimer's disease (AD) [80]. In addition,
AD patients displayed aberrant NOR [81] and reduced levels of mature
rRNAproducts [82]. At themolecular level, Pietrzak et al. (2011) recentlyiated toxicity in polyglutamine disease and other neurodegenerative disorders.
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[32], indicating an epigenetic dysregulation in AD. Identifying the path-
ogenic molecules/molecular events that cause rRNA hypermethylation
will be the next challenge to a more thorough understanding of the
role of nucleolar dysfunction in AD.
10. Concluding remarks and outlook
Elucidating the role of NCL in RNA-mediated nucleolar stress [28,69]
is only the beginning for understanding rRNA dysregulation in polyQ
disease. Expanded CAG transcripts exist in many different conforma-
tions and form macromolecular intra-nuclear RNA foci. Knowing the
particular form(s) of expanded CAG transcripts that are capable of in-
teracting with NCL will allow us to gain further insights into how path-
ogenic RNAs interfere with NCL/UCE interaction. The rrs1 gene is a
regulatory protein of rRNA transcription [83], and has been reported to
be up-regulated in polyQ patients [84]. How rrs1 expression is induced
and how its overexpression inﬂuences rRNA transcription in polyQ dis-
ease remains a mystery. It is anticipated that nucleolar stress in polyQ
degeneration involves the interplay between expanded CAG transcripts
and polyQ proteins. We are beginning to understand the RNA- and
protein-mediated nucleolar stress pathways independently in polyQ
degeneration. Expanded CAG transcripts may induce nucleolar stress
by interrupting the epigenetic regulation of rRNA transcription [28,69],
and that expanded polyQ protein-induced UPR may down-regulate
rRNA transcription by altering the transcription activity of TIF-IA via
post-translational modiﬁcation [20,53]. Forthcoming challenges to re-
searchers in this ﬁeld include how, at the molecular level, expanded
CAG transcript and polyQ protein join forces to induce neuronal cell
dysfunction/death. It is also hoped that amore thorough understanding
of the role the nucleolus plays in polyQ disease will further shed lights
on nucleolar dysfunctions observed in other neurodegenerative disor-
ders, such as AOA1, PD and AD (Fig. 1).
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